VILDAGLIPTINE/METFORMINE ALTER 50 mg/1000 mg, tablet 60 tablets
Active ingredients: Metformin hydrochloride, Metformin, Vildagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VILDAGLIPTINE/METFORMINE ALTER 50 mg/1000 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquettes polyamide aluminium PVC-Aluminium de 60 comprimés
- Marketing authorisation holder
- LABORATOIRES ALTER
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61327301CIP73024559CIP133400930245590Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| METFORMINEcomprimé | 779,86 mg · un comprimé | FT |
| CHLORHYDRATE DE METFORMINEcomprimé | 1000 mg · un comprimé | SA |
| VILDAGLIPTINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.